Mitochondrial Disease: A Historical, Biochemical, and London Perspective

Neurochemical Research

Volumn 29, Issue 3, 2004, Pages 483-491

  Land, John M ^a,b   Morgan Hughes, John A ^b   Hargreaves, Iain ^a,b   Heales, Simon J R ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Mitochondrial disease; Mitochondrial encephalomyopathy; Mitochondrial medicine; Respiratory chain disorders

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA;

CLINICAL RESEARCH; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; GENOTYPE PHENOTYPE CORRELATION; HISTORY OF MEDICINE; HUMAN; MITOCHONDRIAL ENCEPHALOMYOPATHY; MUSCLE BIOPSY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

EID: 1542378002     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000014819.53972.b0     Document Type: Review

References (64)

1. Ernster, L., Ikkos, D., and Luft, R. 1959. Enzymatic activities of human skeletal muscle mitochondria: A tool in clinical metabolic research. Nature 184:1851-1854.
2. Luft, R., Ikkos, D., Palmieri, G., Ernster, L., and Afzelius, B. 1962. A case of severe hypermetabolism of non-thyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical and morphological study. J. Clin. Invest. 41:1776-1804.
3. DiMauro, S., Bonilla, E., Lee, C. P., Schottland, D. L., Scarpa, A., Conn, H., and Chance, B. 1976. Luft's disease: Further biochemical and ultrastructural studies of skeletal muscle in the second case. J. Neurol. Sci. 27:217-232.
4. Mitchell, P. 1966. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Glynn Research Laboratories, Bodmin, UK.
5. Mitchell, P. 1976. Possible molecular mechanisms of the proton motive function of cytochrome systems. J. Theor. Biol. 62:327-367.
6. Palmer, J. M. 1979. The 'Uniqueness' of Plant Mitochondria. Biochem. Soc. Trans. 7:246-252.
7. Seligman, A. M., Karnovsky, M. J., Wasserkrug, H. L., and Hanker, J. S. 1968. Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J. Cell Biol. 38:1-14.
8. Engel, W. and Cunningham, C. 1963. Rapid examination of muscle tissue, an improved trichrome stain method for fresh-frozen biopsy sections. Neurology 13:919-923.
9. Shy, G. M. and Gonatas, N. 1964. Human myopathy with giant abnormal mitochondria. Science 145:493-496.
10. Drachman, D. 1968. Ophthalmoplegia plus: The neurodegenerative disorders associated with progressive external opthalmoplegia. Arch. Neurol. 18:654-674.
11. Morgan-Hughes, J. A., Darveniza, P., Kahn, S. N., Landon, D. N., Sherratt, R. M., Land, J. M., and Clark, J. B. 1977. A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b. Brain 100:617-640.
12. Olson, W., Engle, W. K., Walsh, G. O., and Einaugler, R. 1972. Oculocraniosomatic neuromuscular disease with 'ragged red' fibres. Arch. Neurol. 26:193-211.
13. Schapira, Y., Harel, S., and Russel, A. 1977. A mitochondrial encephalomyopathy: A group of neuromuscular disorders with defects in oxidative metabolism. Israel J. Med. Sci. 13:161-164.
14. Luft, R. 1994. The development of mitochondrial medicine. PNAS 91:8731-8738.
15. Luft, R. 1995. The development of mitochondrial medicine. Biochim. Biophys. Acta. 1271:1-6.
16. Makinen, M. W. and Lee, C. P. 1968. Biochemical studies of skeletal muscle mitochondria: I. Microanalysis of cytochrome content, oxidative and phosphorylative activies of mammalian skeletal muscle mitochondria. Arch. Biochem. Biophys. 126:75-82.
17. Chance, B. and Hagihara, B. 1960. Biochem. Biophys. Res. Commun. 3:1-5.
18. Land, J. M. and Clark, J. B. 1979. Mitochondrial myopathies. Biochem. Soc. Trans. 7:231-245.
19. Morgan-Hughes, J. A. and Hanna, M. G. 1999. Mitochondrial encephalomyopathies: The enigma of genotype versus phenotype. Biochim. Biophys. Acta. 1410:125-145.
20. Nass, S. and Nass, M. 1963. Intramitochondrial fibers with DNA characteristics: I. Fixation and electron staining reactions. J. Cell Biol. 19:593-612.
21. Holt, I. J., Harding, A. E., and Morgan-Hughes, J. A. 1988. Deletions of muscle mitochondria DNA in patients with mitochondrial myopathies. Nature 331:717-719.
22. Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M., et al. 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-1430.
23. Weatherall, D. J. 1982. The New Genetics and Clinical Practise, OUP, Oxford, UK.
24. Spiro, A. J., Moore, C. L., Prinea, J. W., Strasberg, P. M., and Rapin, I. 1970. A cytochrome-related inherited disorder of the nervous system and muscle. Arch. Neurol. 23:103-112.
25. Andreu, A. L., Hanna, M. G., Reichmann, H., Bruno, C., and Penn, A. S. 1999. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. NEJM 341:1037-1044.
26. Mazat, J. P., Rossignol, R., Malgat, M., Rocher, C., Faustin, B., and Letellier, T. 2001. What do mitochondrial diseases teach us about normal mitochondrial functions . . . that we already knew: Threshold expression of mitochondrial defects. Biochim. Biophys. Acta. 1504:20-30.
27. Davey, G. P., Peuchen, S., and Clark, J. B. 1998. Energy thresholds in brain mitochondria: Potential involvement in neurodegeneration. J. Biol. Chem. 273:12753-12757.
28. Munnich, A., Rotig, A., Chretien, D., Cormier, V., Bourgeron, T., Bonnefont, J. P., et al. 1996. Clinical presentation of mitochondrial disorders in childhood. J. Inher. Metab. Dis. 19:521-527.
29. Chinnery, P. F., Johnson, M. A., Wendall, T. M., Singh-Kler, R., Hayes, C., Brown, D. T., et al. 2000. The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neuro. 48:188-193.
30. Skladal, D., Halliday, J., and Thorburn, D. R. 2003. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905-1912.
31. Borchert, A., Wolf, N. I., and Wilichowski, E. 2002. Current concepts of mitochondrial disorders in childhood. Semin. Pediatr. Neurol. 9:151-159.
32. Byrne, E. 2002. Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders? J. Clin. Neurosci. 9:497-450.
33. Calabrese, V., Scapagnini, G., Giuffrida-Stella, A. M., Bates, T. E., and Clark, J. B. 2001. Mitochondrial involvement in brain function and dysfunction: Relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26:739-764.
34. Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., et al. 2002. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219-223.
35. Harmen, D. 1972. The biologic clock: The mitochondria? J. Am. Geriatr. Soc. 20:145-147.
36. Clark, J. B., Bates, T. E., Boakye, P., Kuimov, A., and Land, J. M. 1996. Investigation mitochondrial defects in brain and skeletal muscle. Pages 151-174, in Turner, A. J. and Batchelard, H. S., (eds.), A Practical Approach to the Investigation of Metabolic Disease. IRL Press, Oxford University Press, Oxford.
37. Kumps, A., Duez, P., and Mardens, Y. 2002. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: A comprehensive table. Clin. Chem. 48:708-717.
38. Barth, P. G., Wanders, R. J., Vreken, P., Janssen, E. A., Lam, J., and Baas. F. 1999. X-Linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J. Inherit. Metab. Dis 22:555-567.
39. Almeida, A., Brooks, K. J., Sammut, I., Keelan, J., Davey, G. P., Clark, J. B., and Bates, T. E. 1995. Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain. Dev. Neurosci. 17:212-218.
40. Bates, T. E., Almeida, A., Heales, S. J., and Clark, J. B. 1994. Postnatal development of the complexes of the electron transport chain in isolated rat brain mitochondria. Dev. Neurosci. 16:321-327.
41. Land, J. M., Booth, R. F., Berger, R., and Clark, J. B. 1977. Development of mitochondrial energy metabolism in rat brain. Biochem. J. 164:339-348.
42. Booth, R. F., Patel, T. B., and Clark, J. B. 1980. The development of enzymes of energy metabolism in the brain of a precocial (guinea pig) and non-precocial (rat) species. J. Neurochem. 34:17-25.
43. Lai, J. C., Walsh, J. M., Dennis, S. C., and Clark, J. B. 1977. Synaptic and non-synaptic mitochondria from rat brain: Isolation and characterization. J. Neurochem. 28:625-631.
44. Clark, J. B. and Nicklas, W. J. 1970. The metabolism of rat brain mitochondria: Preparation and characterization. J. Biol. Chem. 245:4724-4731.
45. Lai, J. C. and Clark, J. B. 1979. Preparation of synaptic and non-synaptic mitochondria from mammalian brain. Methods Enzymol. 55:51-60.
46. Booth, R. F. and Clark, J. B. 1978. The control of pyruvate dehydrogenase in isolated brain mitochondria. J. Neurochem. 30:1003-1008.
47. Booth, R. F. and Clark, J. B. 1981. Energy metabolism in rat brain: Inhibition of pyruvate decarboxylation by 3-hydroxybutyrate in neonatal mitochondria. J. Neurochem. 37:179-185.
48. Cullingford, T. E., Clark, J. B., and Phillips, I. R. 1994. The pyruvate dehydrogenase complex: Cloning of the rat somatic E1 alpha subunit and its coordinate expression with the mRNAs for the E1 beta, E2, and E3 catalytic subunits in developing rat brain. J. Neurochem. 62:1682-1690.
49. Byrne, E., Hayes, D. J., Shoubridge, E. A., Morgan-Hughes, J. A., and Clark, J. B. 1985. Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle: Biological effects of the mitochondrial uncoupling agent 2,4-dinitrophenol. Biochem. J. 229:101-18.
50. Hayes, D. J., Byrne, E., Shoubridge, E. A., Morgan-Hughes, J. A., and Clark, J. B. 1985. Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle: Biological effects of the NADH:coenzyme Q reductase inhibitor diphenyleneiodonium. Biochem. J. 229:109-117.
51. Cooper, J. M., Petty, R. K., Hayes, D. J., Challiss, R. A., Brosnan, M. J., Shoubridge, E. A., et al. 1988. An animal model of mitochondrial myopathy: A biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodonium. J. Neurol. Sci. 83:335-347.
52. Cooper, J. M., Petty, R. K., Hayes, D. J., Morgan-Hughes, J. A., and Clark, J. B. 1988. Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats: An animal model of impaired oxidative phosphorylation (mitochondrial myopathy). Biochem. Pharmacol. 37:687-694.
53. Bates, T. E., Heales, S. J., Davies, S. E., Boakye, P., and Clark, J. B. 1994. Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: Evidence for a primary involvement of energy depletion. J. Neurochem. 63:640-648.
54. Heales, S. J., Davies, S. E., Bates, T. E., and Clark, J. B. 1995. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem. Res. 20:31-38.
55. Haines, A. M., Cooper, J. M., Morgan-Hughes, J. A., Clark, J. B., and Schapira, A. H. 1992. One-step immunoaffinity purification of complex subunits from beef heart mitochondria. Protein Expr. Purif. 3:223-227.
56. Schapira, A. H., Cooper, J. M., Morgan-Hughes, J. A., Patel, S. D., Cleeter, M. J., Ragan, C. I., and Clark, J. B. 1988. Molecular basis of mitochondrial myopathies: Polypeptide analysis in complex-I deficiency. Lancet 1:500-503.
57. Cooper, J. M., Hayes, D. J., Challiss, R. A., Morgan-Hughes, J. A., and Clark, J. B. 1992. Treatment of experimental NADH ubiquinone reductase deficiency with menadione. Brain 115:991-1000.
58. White, E. J. and Clark, J. B. 1988. Menadione-treated synaptosomes as a model for post-ischaemic neuronal damage. Biochem. J. 253:425-433.
59. Heales, S. J., Bolanos, J. P., Land, J. M., and Clark, J. B. 1994. Trolox protects mitochondrial complex IV from nitric oxide-mediated damage in astrocytes. Brain Res. 668:243-245.
60. Schapira, A. H., Cooper, J. M., Morgan-Hughes, J. A., Landon, D. N., and Clark, J. B. 1990. Mitochondrial myopathy with a defect of mitochondrial-protein transport. N. Engl. J. Med. 323:37-42.
61. Hardy, L., Clark, J. B., Darley-Usmar, V. M., Smith, D. R., and Stone, D. 1991. Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (complex I) activity in the hypoxic/reoxygenated rat heart. Biochem. J. 274:133-137.
62. Bolanos, J. P., Peuchen, S., Heales, S. J., Land, J. M., and Clark, J. B. 1994. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:910-916.
63. Rahman, S., Hargreaves, I., Clayton, P., and Heales, S. 2001. Neonatal presentation of coenzyme Q10 deficiency. J. Pediatr. 139:456-458.
64. Burne, J. 2003. The hidden power to heal. The Independent Review, London, April 23, p. 8.